7 Questions Every Biotech CEO Should Ask Before Outsourcing an Oncology Trial in Europe 

by Bilyana Petrova | Oct 1, 2025 | News

Outsourcing an Oncology Trial in Europe: 7 Questions for Biotech CEOs If you’re a biotech CEO weighing where and with whom to run oncology clinical trials in Europe, the margin for error is thin. Even though the EU’s Clinical Trials Regulation (CTR 536/2014) has...

APICES acknowledged for its role in PALBOBIN clinical trial 

by Bilyana Petrova | Sep 24, 2025 | News

We are proud to announce that APICES has been acknowledged for its ongoing collaboration in PALBOBIN Trial, a Phase IB clinical trial in Breast Cancer (TNBC). This acknowledgement was highlighted in the Journal of Cancer Research Communications. ...

Egle Pavyde appointed as VP of Business Development

by Bilyana Petrova | Sep 15, 2025 | News

We are thrilled to announce that Egle Pavyde has joined APICES CRO as Vice President of Business Development. With over 10 years of experience in the clinical trials field, she brings the expertise needed to help APICES’ clients...

Facing Clinical Research Challenges? Here’s How to Succeed.

by Bilyana Petrova | Sep 10, 2025 | News

Biotechs operate under enormous pressure: they need to deliver solid scientific results, meet tight deadlines, manage limited resources, and navigate an increasingly demanding regulatory environment in our clinical research. With no room for error, success...

APICES acknowledged for its role in CABOMAYOR clinical trial 

by Bilyana Petrova | Sep 10, 2025 | Uncategorized

We are proud to announce that APICES has been acknowledged for its ongoing collaboration in the CABOMAYOR Trial, a Phase II clinical trial in metastatic renal cell carcinoma (mRCC). This acknowledgement was highlighted in the Journal of Geriatric...